Silvercrest Asset Management Group LLC Has $21.14 Million Stock Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Silvercrest Asset Management Group LLC increased its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 44.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 998,505 shares of the company's stock after purchasing an additional 309,481 shares during the quarter. Silvercrest Asset Management Group LLC owned 0.79% of Surgery Partners worth $21,138,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also made changes to their positions in SGRY. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after buying an additional 465 shares in the last quarter. Wells Fargo & Company MN grew its position in Surgery Partners by 1.4% in the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock valued at $1,205,000 after purchasing an additional 783 shares in the last quarter. MeadowBrook Investment Advisors LLC increased its stake in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after buying an additional 1,460 shares during the last quarter. KBC Group NV increased its stake in Surgery Partners by 66.1% in the 4th quarter. KBC Group NV now owns 3,962 shares of the company's stock valued at $84,000 after buying an additional 1,577 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of Surgery Partners by 1.3% during the 4th quarter. Rhumbline Advisers now owns 121,852 shares of the company's stock worth $2,580,000 after buying an additional 1,588 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Benchmark restated a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a report on Monday, April 21st. Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Surgery Partners currently has a consensus rating of "Moderate Buy" and an average target price of $34.75.

Surgery Partners Stock Performance

NASDAQ:SGRY traded down $0.08 during mid-day trading on Thursday, hitting $22.59. The stock had a trading volume of 166,537 shares, compared to its average volume of 1,097,378. The company's 50 day simple moving average is $22.53 and its 200 day simple moving average is $23.11. The stock has a market cap of $2.90 billion, a price-to-earnings ratio of -47.10, a PEG ratio of 19.21 and a beta of 1.96. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The business had revenue of $776.00 million during the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.10 earnings per share. On average, equities research analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total value of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares of the company's stock, valued at $1,527,498.72. This represents a 4.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David T. Doherty sold 6,733 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.02, for a total transaction of $161,726.66. Following the sale, the chief financial officer now owns 150,868 shares of the company's stock, valued at $3,623,849.36. This trade represents a 4.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.30% of the company's stock.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.